Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056

The mGluR theory of fragile X mental retardation

Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580

Absence of expression of the FMR-1 gene in fragile X syndrome

Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476

Varieties of Repetitive Behavior in Autism: Comparisons to Mental Retardation

Bodfish, J. W., Symons, F. J., Parker, D. E., & Lewis, M. H. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005596502855 · Cited by 1,223

Correction of Fragile X Syndrome in Mice

Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979

DNA methylation represses FMR-1 transcription in fragile X syndrome

Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680

The Fragile X Syndrome Protein FMRP Associates with BC1 RNA and Regulates the Translation of Specific mRNAs at Synapses

Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676

Advances in the Treatment of Fragile X Syndrome

Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-0317 · Cited by 596

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP

Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521

Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome

McBride, S. M. J., Choi, C. H., Wang, Y., Liebelt, D. A., Braunstein, E. M., Ferreiro, D., Sehgal, A., Siwicki, K. K., Dockendorff, T. C., Nguyen, H. T., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.038 · Cited by 484

Individual differences in reward responding explain placebo-induced expectations and effects

Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.028 · Cited by 466

Examining the influence of social‐environmental variables on self‐injurious behaviour in adolescent boys with fragile X syndrome

Hall, S. S., Hustyi, K. M., & Barnett, R. P. (2018) · Journal of Intellectual Disability Research · doi:10.1111/jir.12489 · Cited by 13

Pharmacology, Signaling and Therapeutic Potential of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators

Kos, J. A., Langiu, M., Hellyer, S. D., & Gregory, K. J. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00213 · Cited by 13

Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency

Jacquemont, S., Birnbaum, S., Redler, S., Steinbach, P. J., & Biancalana, V. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.55 · Cited by 14

Interplay Between Macular Retinal Changes and White Matter Integrity in Early Alzheimer’s Disease

Alves, C., Jorge, L., Canário, N., Santiago, B., Santana, I. J., Castelhano, J., Ambrósio, A. F., Bernardes, R., & Castelo-Branco, M. S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190152 · Cited by 15

Resource-frugal classification and analysis of pathology slides using image entropy

Frank, S. J. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2020.102388 · Cited by 11

Evaluating Social Interactions Using the Autism Screening Instrument for Education Planning-3rd Edition (ASIEP-3): Interaction Assessment in Children and Adults with Fragile X Syndrome

Cordeiro, L., Braden, M. L., Coan, E., Welnick, N., Tanda, T., & Tartaglia, N. R. (2020) · Brain Sciences · doi:10.3390/brainsci10040248 · Cited by 16

Adaptive Skills in FXS: A Review of the Literature and Evaluation of the PEDI-Computer Adaptive Test (PEDI-CAT) to Measure Adaptive Skills

Cordeiro, L., Villagomez, A. N., Swain, D. M., Deklotz, S., & Tartaglia, N. R. (2020) · Brain Sciences · doi:10.3390/brainsci10060351 · Cited by 12

Olympic coaching excellence: A quantitative study of psychological aspects of Olympic swimming coaches

Cook, G. M., Fletcher, D., & Peyrebrune, M. (2020) · Psychology of sport and exercise · doi:10.1016/j.psychsport.2020.101876 · Cited by 17

Group I and group II metabotropic glutamate receptors are upregulated in the synapses of infant rats prenatally exposed to valproic acid

D’Antoni, S., Schiavi, S., Buzzelli, V., Giuffrida, S., Feo, A., Ascone, F., Busceti, C. L., Nicoletti, F., Trezza, V., & Catania, M. V. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06457-w · Cited by 11

A blueprint for research on Shankopathies: A view from research on autism spectrum disorder

Carbonetto, S. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22150 · Cited by 13

A ‘learning platform’ approach to outcome measurement in fragile X syndrome: a preliminary psychometric study

Hall, S. S., Hammond, J. L., Hirt, M., & Reiss, A. L. (2012) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2012.01560.x · Cited by 12

Discovery and structure–activity relationship of 1,3-cyclohexyl amide derivatives as novel mGluR5 negative allosteric modulators

Zhou, H., Topiol, S. W., Grenon, M., Jimenez, H. N., Uberti, M. A., Smith, D. G., Brodbeck, R. M., Chandrasena, G., Pedersen, H., Madsen, J. C., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.12.078 · Cited by 12

Biodistribution of 212Pb conjugated trastuzumab in mice

Schneider, N. R., Lobaugh, M., Tan, Z., Sandwall, P. A., Chen, P., Glover, S. E., Cui, L., Murry, M. M., Dong, Z., Torgue, J. J.-C., et al. (2012) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-012-2243-7 · Cited by 13

Incorporating patient-reported outcome measures into the electronic health record for research: application using the Patient Health Questionnaire (PHQ-9)

Griffith, S. D., Thompson, N. R., Rathore, J., Jehi, L. E., Tesar, G. E., & Katzan, I. L. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0764-y · Cited by 15

Hematopoietic stem cells and solid organ transplantation

Elahimehr, R., Scheinok, A. T., & McKay, D. B. (2016) · Transplantation Reviews · doi:10.1016/j.trre.2016.07.005 · Cited by 12

Genetic Biomarkers in Alzheimer’s Disease

Khan, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804832-0.00004-3 · Cited by 13

Hyaluronic acid adsorption on nanodiamonds: Quantitative characteristics and mechanism

Sinolits, A. V., Chernysheva, M. G., Popov, A. G., Egorov, A. V., & Badun, G. A. (2021) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2021.126461 · Cited by 12

BioInnovate Ireland—Fostering Entrepreneurial Activity Through Medical Device Innovation Training

Bruzzi, M., & Linehan, J. H. (2013) · Annals of Biomedical Engineering · doi:10.1007/s10439-013-0787-5 · Cited by 12

Activity-dependent alterations in the sensitivity to BDNF-TrkB signaling may promote excessive dendritic arborization and spinogenesis in fragile X syndrome in order to compensate for compromised postsynaptic activity

Kim, S. W., & Cho, K. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.07.007 · Cited by 14

Molecular basis for prospective pharmacological treatment strategies in intellectual disability syndromes

Verpelli, C., Galimberti, I., Gomez‐Mancilla, B., & Sala, C. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22093 · Cited by 14

Fragile X Syndrome and Autism

Farzin, F., & Koldewyn, K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_8 · Cited by 13

Primary T cells for mRNA-mediated immunotoxin delivery

Eggers, R., Philippi, A., Altmeyer, M. O., Breinig, F., & Schmitt, M. (2017) · Gene Therapy · doi:10.1038/gt.2017.87 · Cited by 10

The effect of nicotine pre-exposure on demand for cocaine and sucrose in male rats

Schwartz, L. P., Kearns, D. N., & Silberberg, A. M. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000357 · Cited by 9

Emergence of Three Dimensional Printed Cardiac Tissue: Opportunities and Challenges in Cardiovascular Diseases

Charbe, N. B., Zacconi, F. C. M., Amnerkar, N. D., Pardhi, D. M., Shukla, P., Mukattash, T. L., McCarron, P. A., & Tambuwala, M. M. (2019) · Current Cardiology Reviews · doi:10.2174/1573403x15666190112154710 · Cited by 11

Molecular analysis of FMR1 alleles for fragile X syndrome diagnosis and patient stratification

Kumari, D., & Usdin, K. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1729744 · Cited by 11

Family Relations in the Genomic Era: Communicating about Intergenerational Transmission of Risk for Disability

Bailey, D. B., Lewis, M. A., Roche, M. I., & Powell, C. M. (2014) · Family Relations · doi:10.1111/fare.12054 · Cited by 11

The Central Role of Etiology in Science and Practice in Intellectual Disability

(2016) · International review of research in developmental disabilities · doi:10.1016/bs.irrdd.2016.05.005 · Cited by 13

Mining and modeling human genetics for autism therapeutics

Smith, D. G., & Ehlers, M. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.03.004 · Cited by 10

Intellectual Disabilities and Global Developmental Delay

Pinchefsky, E. F., & Shevell, M. I. (2017) · Springer eBooks · doi:10.1007/978-3-319-57196-6_2 · Cited by 10

Intrauterine and postnatal growth failure with normal GH/IGF1 axis and insulin-resistant diabetes in a consanguineous kinship

Guevara‐Aguirre, J., Guevara‐Aguirre, M., Hwa, V., Prócel, P., Saavedra, J., D, H. O. M., Peng, F., Rosenfeld, R. G., Kerns, S. L., & Rosenbloom, A. L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0769 · Cited by 10

Observations in lung cancer over multiple decades: an analysis of outcomes and cost at a single high-volume institution

Lanuti, M. D., Hong, H.-J., Ali, S. N., Stock, C. T., Temel, J. S., Mathisen, D. J., & Michaelson, J. S. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezt611 · Cited by 10

Pediatric Quality of Life Inventory (PedsQL) in Fragile X Syndrome

Fitzpatrick, S. E., Schmitt, L., Adams, R. E., Pedapati, E. V., Wink, L. K., Shaffer, R. C., Sage, J., Weber, J. D., Dominick, K. C., & Erickson, C. A. (2019) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-04292-7 · Cited by 10

Doxycycline Attenuates Lipopolysaccharide-Induced Microvascular Endothelial Cell Derangements

Wiggins-Dohlvik, K. C., Stagg, H. W., Han, M. S., Alluri, H., Oakley, R. P., Shaji, C. A., Davis, M. L., & Tharakan, B. (2015) · Shock · doi:10.1097/shk.0000000000000556 · Cited by 10

Fragile X syndrome: Current insight

Dean, D. D., Muthuswamy, S., & Agarwal, S. (2016) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2016.01.005 · Cited by 11

Akne und Ernährung

Melnik, B. C. (2013) · Der Hautarzt · doi:10.1007/s00105-012-2461-5 · Cited by 10

Genomics, clinical research, and learning health care systems: Strategies to improve patient care

Williams, J. K., Cashion, A. K., Shekar, S. S., & Ginsburg, G. S. (2015) · Nursing Outlook · doi:10.1016/j.outlook.2015.12.006 · Cited by 9

Neurobehavioral features and targeted treatments in fragile X syndrome: Current insights and future directions

Budimirovic, D. B., & Duy, P. Q. (2015) · Engrami · doi:10.5937/engrami1504005b · Cited by 9

Vector enabled CRISPR gene editing – A revolutionary strategy for targeting the diversity of brain pathologies

Forgham, H., Liu, L., Zhu, J., Javed, I., Cai, W., Qiao, R., & Davis, T. P. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215172 · Cited by 9

Alcohol Medications Development: Advantages and Caveats of Government/Academia Collaborating with the Pharmaceutical Industry

Litten, R. Z., Ryan, M., Falk, D. E., & Fertig, J. B. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12357 · Cited by 9

Synthesis, spectral characterization and inhibitory potency of ferrocene‐containing mannosides towards type 1 fimbriated Escherichia coli

Kovač, V., Ribić, R., Peroković, V. P., Tomić, S., & Barišić, L. (2016) · Applied Organometallic Chemistry · doi:10.1002/aoc.3465 · Cited by 9

Patient‐individualized CD 8+ cytolytic T ‐cell therapy effectively combats minimal residual leukemia in immunodeficient mice

Distler, E., Albrecht, J. D., Brunk, A., Khan, S. A., Schnürer, E., Frey, M., Mottok, A., Garrote, A.-L. J., Brede, C., Beilhack, A., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29854 · Cited by 9

Synaptic Plasticity, a Prominent Contributor to the Anxiety in Fragile X Syndrome

Yang, T., Zhao, H., Lu, C., Li, X., Xie, Y., Fu, H., & Xu, H. (2016) · Neural Plasticity · doi:10.1155/2016/9353929 · Cited by 9

Classification of Tissue Regions in Histopathological Images: Comparison Between Pre-trained Convolutional Neural Networks and Local Binary Patterns Variants

Kather, J. N., Bello-Cerezo, R., Maria, F. D., van Pelt, G. W., Mesker, W. E., Halama, N., & Bianconi, F. (2020) · Intelligent systems reference library · doi:10.1007/978-3-030-42750-4_3 · Cited by 9

Discovery of VU0431316: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety

Bates, B. S., Rodriguez, A. L., Felts, A. S., Morrison, R. D., Venable, D. F., Blobaum, A. L., Byers, F. W., Lawson, K. P., Daniels, J. S., Niswender, C. M., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.003 · Cited by 9

Encapsulated specialty oils commercialized in São Paulo state, Brazil: evaluation of identity (fatty acid profile) and compliance of fatty acids and Vitamin E contents with nutrition labeling

Hirashima, K., Silva, S. A., Caruso, M. S. F., & Aued-Pimentel, S. (2013) · Food Science and Technology · doi:10.1590/s0101-20612013005000022 · Cited by 9

Fragile X-associated tremor/ataxia syndrome: another phenotype of the fragile X gene

Hessl, D. R., & Grigsby, J. (2016) · The Clinical Neuropsychologist · doi:10.1080/13854046.2016.1186661 · Cited by 10

Genetic testing of adults with intellectual disability

de Villiers, J., & Porteous, M. E. (2012) · The Psychiatrist · doi:10.1192/pb.bp.111.038216 · Cited by 8

Synthesis of 5-(S)-HETE, 5-(S)-HEPE and (+)-zooxanthellactone: Three hydroxylated polyunsaturated fatty acid metabolites

Primdahl, K. G., Stenstrøm, Y., Hansen, T. V., & Vik, A. (2016) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2015.12.005 · Cited by 8

Genetic Approaches to Understanding Psychiatric Disease

Michaelson, J. J. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0551-x · Cited by 11

Increase in visceral adipose tissue and subcutaneous adipose tissue thickness in children with acute pancreatitis. A case-control study

Bükülmez, A., Gökaslan, Ç. Ö., & Oflu, A. T. (2020) · Archives de Pédiatrie · doi:10.1016/j.arcped.2020.10.011 · Cited by 8

Progress toward therapeutic potential for AFQ056 in Fragile X syndrome

Doering, L. C., Sourial, M. M., & Cheng, C. (2013) · Journal of Experimental Pharmacology · doi:10.2147/jep.s27044 · Cited by 8

Transmitted/Founder Simian Immunodeficiency Virus Envelope Sequences in Vesicular Stomatitis and Semliki Forest Virus Vector Immunized Rhesus Macaques

Gambhira, R., Keele, B. F., Schell, J. B., Hunter, M., Dufour, J., Montefiori, D. C., Tang, H., Rose, J. K., Rose, N. F., & Marx, P. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109678 · Cited by 8

Cigarette Smoking and Quit Attempts Among Injection Drug Users in Tijuana, Mexico

Shin, S. S., Moreno, P. G., Rao, S. D., Garfein, R. S., Novotny, T., & Strathdee, S. A. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt099 · Cited by 8

Increased Cervical Human Immunodeficiency Virus (HIV) RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure Compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3

Greene, S. A., McGrath, C. J., Lehman, D. A., Marson, K. G., Trinh, T. T., Yatich, N., Nyongesa‐Malava, E., Kiptinness, C., Richardson, B. A., John-Stewart, G. C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1096 · Cited by 8

Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV

Kim, J., Bu, W., Mine, S., Tariq, Z., Nguyen, H., Wang, Y., Tolman, C. J., Mond, J., & Cohen, J. I. (2021) · Virology · doi:10.1016/j.virol.2021.06.006 · Cited by 8

N-methyl- -aspartate receptor antagonism modulates P300 event-related potentials and associated activity in salience and central executive networks

de la Salle, S., Shah, D. K., Choueiry, J., Bowers, H., McIntosh, J. F., Carroll, B., Ilivitsky, V., & Knott, V. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173287 · Cited by 8

Safety Pharmacology Evaluation of Biopharmaceuticals

Amouzadeh, H. R., Engwall, M. J., & Vargas, H. M. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46943-9_15 · Cited by 8

The most influential researchers in information behaviour

Soheili, F., Khasseh, A. A., & Chelak, A. M. (2017) · Aslib Journal of Information Management · doi:10.1108/ajim-01-2017-0027 · Cited by 8

Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndrome

Protic, D. D., Breeze, E., Mendoza‐Morales, G., Zafarullah, M., Abbeduto, L., Hagerman, R. J., Coffey, C. S., Cudkowicz, M., Durbin-Johnson, B. P., Ashwood, P., et al. (2024) · SAGE Open Medicine · doi:10.1177/20503121241282401 · Cited by 7

Reengineering Biomedical Translational Research with Engineering Ethics

Sunderland, M. E., & Nayak, R. U. (2014) · Science and Engineering Ethics · doi:10.1007/s11948-014-9567-3 · Cited by 7

Sickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In Vivo

Sun, C. W., Willmon, C. L., Wu, L.-C., Knopick, P. L., Thoerner, J., Vile, R. G., Townes, T. M., & Terman, D. S. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00166 · Cited by 7

A test of psychological and electrodermal changes immediately after the delivery of 3 analgesic treatment messages

Geers, A. L., Fowler, S. L., Helfer, S. G., & Murray, A. B. (2019) · PAIN Reports · doi:10.1097/pr9.0000000000000693 · Cited by 7

Evaluation of enzymatic and magnetic properties of γ-glutamyl-[1- 13 C]glycine and its deuteration toward longer retention of the hyperpolarized state

Kondo, Y., Saito, Y., Elhelaly, A. E., Hyodo, F., Nishihara, T., Itoda, M., Nonaka, H., Matsuo, M., & Sando, S. (2021) · RSC Advances · doi:10.1039/d1ra07343e · Cited by 7

Tuberculosis in the 21st century

Friedland, J. S. (2011) · Clinical Medicine · doi:10.7861/clinmedicine.11-4-353 · Cited by 7

Biomarkers in T-cell therapy clinical trials

Lacey, S. F., & Kalos, M. D. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.01.002 · Cited by 7

Safety and Immunogenicity of Cell Culture-Derived A/H3N2 Variant Influenza Vaccines: A Phase I Randomized, Observer-Blind, Dose-Ranging Study

Johnson, C., Hohenboken, M. J., Poling, T. L., Jaehnig, P., & Kanesa-thasan, N. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu826 · Cited by 7

Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist‐utility index

Raspa, M., Sacco, P., Candrilli, S. D., Bishop, E. E., & Petrillo, J. (2016) · Journal of Intellectual Disability Research · doi:10.1111/jir.12264 · Cited by 7

Targeting Mitochondrial Fission-Fusion Imbalance in Heart Failure

Menezes, T. N., Ramalho, L. S., Bechara, L. R. G., & Ferreira, J. C. B. (2020) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-020-00023-8 · Cited by 7

Fusion expression of the two soluble viral receptors of porcine reproductive and respiratory syndrome virus with a single adeno-associated virus vector

Liu, X., Xia, W., Zhang, X., Xia, X., & Sun, H. (2021) · Research in Veterinary Science · doi:10.1016/j.rvsc.2020.12.026 · Cited by 7

Can expensive research equipment boost research and development performances?

Lee, K., Choi, S., & Yang, J. (2021) · Scientometrics · doi:10.1007/s11192-021-04088-6 · Cited by 7

Human iPSC Models in Drug Discovery: Opportunities and Challenges

Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6

Erasing “bad memories”: reversing aberrant synaptic plasticity as therapy for neurological and psychiatric disorders

Shi, Z., Wen, K., Sammudin, N. H., LoRocco, N. C., & Zhuang, X. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03013-0 · Cited by 7

Challenges in developing therapies in fragile X syndrome: how the FXLEARN trial can guide research

Neul, J. L. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175036 · Cited by 6

Emerging autism and Fragile X syndrome treatments

Parkhill, M., Salmaso, N., D’Angiulli, A., Lee, V., & Aguilar‐Valles, A. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2025.02.004 · Cited by 7

Translational Medicine Strategies in Drug Development for Neurodevelopmental Disorders

Srivastava, S., Şahin, M., & Prock, L. A. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-803161-2.00022-9 · Cited by 6

Quickly Evaluating an Emerging Medical Technology Using Feedback From the Field: A Case Study of the BrainScope One and Infrascanner 2000 User Evaluation

Krauss, S. W., Sanjakdar, S. S., Wilson, A., Dacanay, B., Jasper, L. E., Adler, A. B., & Funari, T. S. (2020) · Military Medicine · doi:10.1093/milmed/usaa069 · Cited by 6

mGluR2 Activators and mGluR5 Blockers Advancing in the Clinic for Major CNS Disorders

Célanire, S., Duvey, G., Poli, S. M., & Rocher, J. (2012) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-396492-2.00006-0 · Cited by 7

From Bench to Practice to Population Health Impact: Barriers to Realizing the Public Health and Clinical Promise of Basic Scientific Discovery

Field, A. P., Baxter, K., & Terry, S. F. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.1518 · Cited by 6

Molecular medicine of fragile X syndrome: based on known molecular mechanisms

Luo, S.-Y., Wu, L., & Duan, R. (2015) · World Journal of Pediatrics · doi:10.1007/s12519-015-0052-0 · Cited by 8

Markov cellular automata models for chronic disease progression

Hawkins, J., & Molinek, D. K. (2015) · International Journal of Biomathematics · doi:10.1142/s1793524515500850 · Cited by 8

New drug development in childhood cancer

Kearns, P. R., & Morland, B. J. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000054 · Cited by 6

The NIH Clinical Center and the future of clinical research

Gallin, J. I. (2011) · Nature Medicine · doi:10.1038/nm.2466 · Cited by 5

New Models for Considering the Role of Medication in the Treatment and Elucidation of the Etiology of Autism

Smile, S., & Anagnostou, E. A. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0326-3 · Cited by 5

Advocacy spurs innovation: promoting synergy between physical and biomedical sciences

Samson, S., Acerbi, I., Baas, C., Weaver, V. M., & Rugo, H. S. (2013) · EPJ Nonlinear Biomedical Physics · doi:10.1140/epjnbp1 · Cited by 5

Review of Salient Investigational Drugs for the Treatment of Fragile X Syndrome

Munshi, K. R., Pawlowski, K. G., Gonzalez–Heydrich, J., & Picker, J. D. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0200 · Cited by 5

Adapting SureSelect enrichment protocol to the Ion Torrent S5 platform in molecular diagnostics of craniosynostosis

Bukowska‐Olech, E., Popiel, D., Koczyk, G., Sowińska‐Seidler, A., Socha, M., Wojciechowicz, B., Dawidziuk, A., Larysz, D., & Jamsheer, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-61048-5 · Cited by 6

From Genes to Therapy in Autism Spectrum Disorder

Vorstman, J. A. S., Freitag, C. M., & Persico, A. M. (2022) · Genes · doi:10.3390/genes13081377 · Cited by 6

Fragile X-Associated Disorders

Lozano, R., Hare, E. B., & Hagerman, R. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00017-6 · Cited by 5

Acne and Genetics

Melnik, B. C. (2014) · Springer eBooks · doi:10.1007/978-3-540-69375-8_14 · Cited by 5

Advancing Laboratory Medicine through Innovation: A Tale of Six Inventors

Rifai, N., Diamandis, E. P., Lo, Y. M. D., Kricka, L. J., Wilding, P. M., Ladenson, J. H., & Wittwer, C. T. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.178582 · Cited by 5

Learning and Memory

Manns, J. R., & Buffalo, E. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385870-2.00048-2 · Cited by 5

Fresh from the designation pipeline: orphan drugs recently designated in the European Union

Antoniu, S. A. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.764822 · Cited by 4

Overview of Targeted Double-Blind, Placebo-Controlled Clinical Trials in Fragile X Syndrome

Ligsay, A., Hagerman, R. J., & Berry‐Kravis, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00019-6 · Cited by 4

Challenges in Conducting Clinical Trials for Pharmacotherapies in Fragile X Syndrome: Lessons Learned

Harkins, C. M., Dominick, K. C., Wink, L. K., Pedapati, E. V., Shaffer, R. C., Fitzpatrick, S. E., Davenport, M. H., Sweeney, J. A., & Erickson, C. A. (2017) · Pharmaceutical Medicine · doi:10.1007/s40290-017-0199-1 · Cited by 4

An Introduction to Translational Informatics and the Future of Knowledge-Driven Healthcare

Payne, P., & Embí, P. J. (2014) · Health informatics · doi:10.1007/978-1-4471-4646-9_1 · Cited by 4

Molecular Mechanisms of Neurological Disease

Gireud, M., Sirisaengtaksin, N., & Bean, A. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397179-1.00021-x · Cited by 5

Fragile X syndrome: a pilot proton magnetic resonance spectroscopy study in premutation carriers

Hallahan, B. P., Daly, E., Simmons, A., Moore, C. J., Murphy, K. C., & Murphy, D. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-23 · Cited by 4

Fragile X-Associated Disorders

Summers, S. M., & Hagerman, R. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00008-2 · Cited by 4

Inhibitory and Excitatory Systems in Autism Spectrum Disorders

Blatt, G. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00024-7 · Cited by 4

Epigenomics – Impact for Drug Safety Sciences

Lempiäinen, H., Luisier, R., Müller, A., Marc, P., Heard, D. J., Bolognani, F., Moulin, P., Couttet, P., Grenet, O., Marlowe, J. L., et al. (2012) · Wiley eBooks · doi:10.1002/9781118349045.ch19 · Cited by 4

Epigenetic modification of the FMR1 gene in fragile X patients leads to a differential response to the mGluR5 antagonist AFQ056

Jacquemont, S., Curie, A., Portes, V. D., Torrioli, M. G., Berry‐Kravis, E., Hageman, R., Ramos, F. J., Cornish, K. M., He, Y., & neri, G. (2011) · Cited by 2

The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitro

Tabolacci, E., Pirozzi, F., Gomez‐Mancilla, B., Gasparini, F., & Neri, G. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-13 · Cited by 15

Progress toward therapeutic potential for AFQ056 in Fragile X syndrome

Doering, L. C., Sourial, M. M., & Cheng, C. (2013) · Journal of Experimental Pharmacology · doi:10.2147/jep.s27044 · Cited by 8

mGlu5 as a potential therapeutic target for the treatment of fragile X syndrome

Robertson, L. (2013) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzt001 · Cited by 1

Fragile X syndrome therapy: to respond or not to respond may be a matter of methylation

Pouladi, M. A. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01663.x · Cited by 1